Affiliation: Leiden University Medical Center
Country: The Netherlands
- Tasquinimod: a novel drug in advanced prostate cancerSusanne Osanto
Department of Clinical Oncology, Leiden University Medical Center, Leiden, 2333ZA, The Netherlands
Future Oncol 9:1271-81. 2013..If the Phase II data are validated in the Phase III trial a new compound with a unique mode of action might become approved as a future therapy for minimally symptomatic mCRPC patients. ..
- Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencingSusanne Osanto
Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
PLoS ONE 7:e38298. 2012..Individual differentially expressed miRNAs may potentially serve as diagnostic or prognostic markers or future therapeutic targets in ccRCC. The biological relevance of candidate novel miRNAs is unknown at present...
- Pre-analytical and analytical issues in the analysis of blood microparticlesYuana Yuana
Department of Clinical Oncology, Leiden University Medical Centre, Leiden, The Netherlands
Thromb Haemost 105:396-408. 2011..Ultimately, standardisation of pre-analytical procedures and the introduction of reliable and rapid methods for the measurement of MPs are urgently needed to facilitate their use as biomarker in the pathophysiology of diseases...